Atherosclerosis is the build-up of plaque in the arteries which causes their narrowing. It is a primary cause of ischemic heart disease (IHD) and ischemic stroke (IS), both of which are major ...

Medical illustration showing how plaque buildup and clot formation can restrict blood flow in arteries. Researchers have developed a luteolin-based nanomedicine that targets and stabilizes these ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Atherosclerosis happens when a fatty substance called plaque builds up inside your arteries. There are typically few noticeable ...

Baker Heart and Diabetes Institute researchers have designed and developed a novel drug delivery method that can vastly improve the efficacy of a drug used to treat atherosclerosis and has the ...

WHO Peter Libby, MD, cardiovascular medicine specialist at Brigham and Women's Hospital and the Mallinckrodt Professor of Medicine at Harvard Medical School; author of a new review paper published in ...

Most cardiovascular events begin with atherosclerosis, a condition in which inflammation and fatty deposits cause arteries to narrow and stiffen. These deposits, or plaques, build up over years. When ...

Researchers have discovered that the smooth muscle cells that line the arteries of people with atherosclerosis can change into new cell types and develop traits similar to cancer that worsen the ...

Data presented at this year’s AHA reinforces the established efficacy profile of CRESTOR (rosuvastatin) Treatment with CRESTOR (rosuvastatin) or atorvastatin for two years resulted in statistically ...

A compound associated with the smell of death may have potential as a treatment for atherosclerosis and other chronic inflammatory diseases. Putrescine, the compound responsible for perhaps the ...

Share on Pinterest Experts note that atherosclerosis is linked to heart disease risk. Susana Ramírez/Stocksy The medication saracatinib has been researched in the past as a potential cancer treatment.